Development and validation of a machine learning-based postoperative prognostic model for plasma cell neoplasia with spinal lesions as initial clinical manifestations: a single-center cohort study-Reference-Cited by-同舟云学术

Development and validation of a machine learning-based postoperative prognostic model for plasma cell neoplasia with spinal lesions as initial clinical manifestations: a single-center cohort study

Published:2024-04-07 Issue: Volume: Page:
ISSN:0940-6719
Container-title:European Spine Journal
language:en
Short-container-title:Eur Spine J

Author:

You Chaoqun,Ren Jiaji,Cheng Linfei,Peng Cheng,Lu Peng,Guo Kai,Zhong Fulong,Wang Jing,Gao Xin,Cao Jiashi,Liu Huancai,Liu Tielong^ORCID

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00586-024-08223-8.pdf

Reference32 articles.

1. Caers J, Paiva B, Zamagni E, Leleu X, Bladé J, Kristinsson SY, Touzeau C, Abildgaard N, Terpos E, Heusschen R, Ocio E, Delforge M, Sezer O, Beksac M, Ludwig H, Merlini G, Moreau P, Zweegman S, Engelhardt M, Rosiñol L (2018) Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European expert panel. J Hematol Oncol 11:10. https://doi.org/10.1186/s13045-017-0549-1

2. Kyle R, Rajkumar S, Myeloma (2009) Treatment of multiple myeloma: a comprehensive review. Clin Lymphoma 9:278–288. https://doi.org/10.3816/CLM.2009.n.056

3. Fend F, Dogan A, Cook JR (2023) Plasma cell neoplasms and related entities-evolution in diagnosis and classification. Virchows Archiv Int J Pathol 482:163–177. https://doi.org/10.1007/s00428-022-03431-3

4. Callander NS, Baljevic M, Adekola K, Anderson LD, Campagnaro E, Castillo JJ, Costello C, Devarakonda S, Elsedawy N, Faiman M, Garfall A, Godby K, Hillengass J, Holmberg L, Htut M, Huff CA, Hultcrantz M, Kang Y, Larson S, Liedtke M, Martin T, Omel J, Sborov D, Shain K, Stockerl-Goldstein K, Weber D, Berardi RA, Kumar R, Kumar SK (2022) NCCN guidelines® Insights: multiple myeloma, version 3.2022. J Natl Compr Cancer Netw JNCCN 20:8–19. https://doi.org/10.6004/jnccn.2022.0002

5. van de Donk N, Pawlyn C, Yong KL (2021) Multiple myeloma. Lancet (London, England) 397:410–427. https://doi.org/10.1016/s0140-6736(21)00135-5